课题基金 / 基金详情

CISAPRIDE IN TREATMENT OF CHILDREN WITH GI MOTILITY DISORDERS

CISAPRIDE IN TREATMENT OF CHILDREN WITH GI MOTILITY DISORDERS
西沙必利治疗胃肠动力障碍儿童
批准号：
3850476
负责人：
PAUL E HYMAN
金额：
$0.0万
依托单位：
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3850476
关键词：
child (0-11) cisapride congenital gastrointestinal disorder drug adverse effect gastrointestinal disorder chemotherapy gastrointestinal motility /pressure human subject human therapy evaluation

项目摘要

项目成果

PAUL E HYMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To determine the safety and efficacy of oral Cisapride on the symptoms of gastrointestinal motility disorders and document any changes with long term treatment on antroduodenal motility and colonic motility/transit in children with GI motility disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CONTROL OF ISOLATED GASTRIC MUSCLE CELL CONTRACTION
CONTROL OF ISOLATED GASTRIC MUSCLE CELL CONTRACTION
CONTROL OF ISOLATED GASTRIC MUSCLE CELL CONTRACTION
CONTROL OF ISOLATED GASTRIC MUSCLE CELL CONTRACTION
海外基金